Hyperimmune bovine colostrum inefficacious as multiple sclerosis therapy in double-blind study

Bayard, B.L.; James, M.A.

Journal of the American Dietetic Association 87(10): 1388-1390

1987


ISSN/ISBN: 0002-8223
PMID: 3309014
Document Number: 297069
A double-blind, placebo-controlled study investigated the use of hyperimmune bovine colostrum (HBC) as a therapy for 12 multiple sclerosis (MS) patients using a protocol designed to suppress placebo responses. It is concluded that, while a retrogression in clinical status was observed in 3 MS patients 6 weeks after they discontinued HBC and an improved function was observed in 2 MS patients who resumed HBC, MS patients with characteristics similar to those studied should be cautioned to guard against unfounded optimism because several plausible explanations for these findings could be identified.(wz)

Document emailed within 1 workday
Secure & encrypted payments